PATENT CLAIM ANALYSIS

Application Number: 15893542
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "465000"]

Abstract:
In one aspect, compositions and methods for the treatment of vulvovaginal atrophy (VVA) are provided. In one embodiment, the method comprises administering an estrogen to a subject having VVA by inserting a dosage form comprising a liquid pharmaceutical composition.

Claim (Index 8):
The method of  claim 1 , wherein administration of the composition results in a decrease in vaginal pH within two weeks from the first administration.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 88.0
- Lexical Diversity: 1.21622
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15893546', '15372385', '15893550', '14521230', '14624051']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8183057750164077
- 35 USC 102 Novelty (BERT): 0.6503410486357821
- Combined Prediction Score: 0.8015093023783451
- Mean Citation Score: 548.485278
- Max Citation Score: 680.72253
- Similarity Product: 592.0308455752802

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test